This site is intended for healthcare professionals
News

FDA approves cobas EZH2 Mutation Test as companion diagnostic for Tazverik in follicular lymphoma.- Roche

Read time: 1 mins
Last updated:23th Jun 2020
Published:21th Jun 2020
Condition: Follicular Lymphoma
Type: drug
Register free for full access to medthority.com